"Our initial experience with the BCA graft began in 2004 and our early impression of this conduit was that it resulted in less inflammatory response at the site of implantation and less infectious complications while also allowing for easier surgical handling."
"Elasticity mismatch between the stiff ePTFE graft and elastic native tissue at the anastomosis site causes wall stress, leading to cell proliferation."
"One approach to solve the problem of compliance mismatch is to use more elastic material such as decellularized xenografts, as AV grafts elastic mismatch problem is to use natural, instead of synthetic material."
"Although only speculative, the lower rate of graft thrombosis may be due to less or slower developing neointimal hyperplasia in the BCA group."
Surgical Versatility
- Artegraft handles and feels like native vessel
- Minimal or no suture line bleeding
- Superior tensile strength permits lateral and longitudinal expansion without weakening the graft.
- Anastomotic compliancy relieves stress, reducing the the likelihood of stenosis and intimal hyperplasia.
Biocompatibility
Artegraft’s 100% biological collagen matrix is nonreactive and nonantigenic.